
Please try another search
Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, and continuous flow; and chemical process R&D, analytical services, regulatory, pre-clinical R&D support, PPQ readiness, and back integration services. It also engages in technology services comprising flow chemistry, biocatalysis, fermentation, chiral synthesis, hazardous reactions, low temperature, highly potent, non-precious metal catalysis (NPMC), high-pressure chemistry, electrochemistry, and photochemistry. In addition, the company offers drug products, such as pharma solutions, preformulation, solid oral dosage, and injectables; and biotech solutions, drug substance and development, and consultation services. The company was founded in 1998 and is headquartered in Tianjin, China.
Name | Age | Since | Title |
---|---|---|---|
Ye Song | 64 | 2011 | Non-Executive Director |
Xinxin Zhi | 45 | 2011 | Chairman of the Supervisory Committee |
Shanshan Di | 39 | 2017 | Shareholder representative Supervisor |
Da Zhang | 44 | 2018 | CFO, COO, Senior VP & Executive Director |
Timothy F. Jamison | - | - | Member of Scientific Advisory Board |
Scott May | - | - | Member of Scientific Advisory Board |
Jingyi Hou | 42 | 2021 | Employee Representative Supervisor |
Hao Hong | 69 | 2011 | Founder, Chairman & CEO |
Weikai Xie | - | 2025 | Independent Non-Executive Director |
Rui Yang | 48 | 2011 | Co-CEO & Executive Director |
Stephen L. Buchwald | - | - | Member of Scientific Advisory Board |
Ting Zhang | 39 | 2021 | Non-Executive Director |
Martin Eastgate | - | - | Member of Scientific Advisory Board |
Phil S. Baran | 48 | - | Member of Scientific Advisory Board |
Kar Chung Lee | 44 | 2021 | Independent Non Executive Director |
Jin-Quan Yu | - | - | Member of Scientific Advisory Board |
Patricia Alred | - | - | Member of Scientific Advisory Board |
Nicholas Turner | - | - | Member of Scientific Advisory Board |
Xuejiao Sun | 42 | 2023 | Independent Non-Executive Director |
Xinyi Hou | 65 | 2024 | Independent Non-Executive Director |
Seble Wagaw | - | - | Member of Scientific Advisory Board |
Liang Hong | 51 | 2011 | Executive VP & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review